Literature DB >> 17596726

Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.

Gang Wang1, Fernand Mac-Moune Lai, Ka-Bik Lai, Kai-Ming Chow, Kam-Tao Philip Li, Cheuk-Chun Szeto.   

Abstract

BACKGROUND: Podocyte loss plays an important role in the pathogenesis of diabetic nephropathy. We hypothesize that messenger RNA expression of podocyte-associated molecules in urinary sediment may provide important clinical information in patients with diabetic nephropathy.
METHOD: We studied 21 patients with biopsy-proven diabetic nephropathy and 9 healthy controls. The mRNA expression of nephrin, podocin, synaptopodin, Wilms' tumor-1 (WT-1) and alpha-actinin-4 in urinary sediment were measured by real-time quantitative polymerase chain reaction. The degree of histological damage was quantified by morphometric analysis. Patients were then followed for an average of 25.63 +/- 10.76 months. The rate of glomerular filtration rate (GFR) decline was calculated by the least-square regression.
RESULTS: There were significant differences in nephrin, podocin, synaptopodin, alpha-actinin-4 (p < 0.01 for all comparisons) and WT-1 (p = 0.028) expression between patients and normal controls. Urinary nephrin expression was significantly correlated with proteinuria (r = 0.502, p = 0.020); urinary synaptopodin was significantly correlated with proteinuria (r = 0.585, p = 0.005), serum creatinine (r = 0.516, p = 0.017) and estimated GFR (r = -0.560, p = 0.008), and urinary WT-1 expression was significantly correlated with the degree of tubulointerstitial fibrosis (r = 0.558, p = 0.009). There was no significant correlation between GFR decline and urinary expression of target genes.
CONCLUSION: Urinary mRNA expressions of nephrin, podocin, synaptopodin, WT-1 and alpha-actinin-4 are higher in patients with diabetic nephropathy than in normal controls. Urinary nephrin and synaptopodin expressions are correlated with baseline clinical parameters such as proteinuria or renal function, while WT-1 expression is related to the degree of histological damage. Our results suggest that urinary mRNA expression of podocyte-associated molecules may be used for risk stratification of diabetic nephropathy. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596726     DOI: 10.1159/000104428

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  26 in total

Review 1.  Genomic biomarkers for chronic kidney disease.

Authors:  Wenjun Ju; Shahaan Smith; Matthias Kretzler
Journal:  Transl Res       Date:  2012-02-09       Impact factor: 7.012

Review 2.  Podocytes from the diagnostic and therapeutic point of view.

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  Pflugers Arch       Date:  2017-05-16       Impact factor: 3.657

3.  Urine podocyte mRNAs mark disease activity in IgA nephropathy.

Authors:  Akihiro Fukuda; Yuji Sato; Takashi Iwakiri; Hiroyuki Komatsu; Masao Kikuchi; Kazuo Kitamura; Roger C Wiggins; Shouichi Fujimoto
Journal:  Nephrol Dial Transplant       Date:  2015-05-08       Impact factor: 5.992

4.  Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy.

Authors:  Song-Tao Feng; Yang Yang; Jin-Fei Yang; Yue-Ming Gao; Jing-Yuan Cao; Zuo-Lin Li; Tao-Tao Tang; Lin-Li Lv; Bin Wang; Yi Wen; Lin Sun; Guo-Lan Xing; Bi-Cheng Liu
Journal:  Clin Kidney J       Date:  2021-09-28

Review 5.  Minimal change nephropathy and focal segmental glomerulosclerosis.

Authors:  Peter W Mathieson
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

6.  Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies.

Authors:  Patrícia Garcia Rodrigues; Rafael Nazário Bringhenti; Jonathan Frapporti do Nascimento; Gabriel Joelsons; Mariane dos Santos; Sane Pereira; Francisco Veríssimo Veronese
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

7.  Effect of simvastatin on the expression of nephrin, podocin, and vascular endothelial growth factor (VEGF) in podocytes of diabetic rat.

Authors:  Shujun Chen; Haiping Chen; Qi Liu; Qing Ma
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome.

Authors:  Bin Zhu; Xian-fa Li; Xiao-ling Zhu; Yi Lin; Sen Zhong; Cai-feng Zhu; Xuan-li Tang; Yun-qing Hu; Xiao-xia Cheng; Yong-jun Wang
Journal:  J Nephrol       Date:  2014-04-16       Impact factor: 3.902

9.  BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression.

Authors:  Tamara Turk; Jan Willem Leeuwis; Julia Gray; Suzy V Torti; Karen M Lyons; Tri Q Nguyen; Roel Goldschmeding
Journal:  J Histochem Cytochem       Date:  2009-03-02       Impact factor: 2.479

10.  Urinary podocyte and TGF-β1 mRNA as markers for disease activity and progression in anti-glomerular basement membrane nephritis.

Authors:  Akihiro Fukuda; Akihiro Minakawa; Yuji Sato; Takashi Iwakiri; Shuji Iwatsubo; Hiroyuki Komatsu; Masao Kikuchi; Kazuo Kitamura; Roger C Wiggins; Shouichi Fujimoto
Journal:  Nephrol Dial Transplant       Date:  2017-11-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.